---
$id: https://graph.org.ai/products/commodity/51161561
$type: Product
source: UNSPSC
code: "51161561"
title: "Pirquinozol"
class: "51161500"
classTitle: "Antiasthmatic drugs"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Pirquinozol

**UNSPSC Code**: 51161561
**Class**: [Antiasthmatic drugs](Antiasthmatic drugs.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-asthmatic agent with the molecular formula C11H9N3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D16HG4V2UC, chemically known as 2-(hydroxymethyl)pyrazolo(1,5-c)quinazolin-5(6h)-one but generally known as pirquinozol, which bears US NIH Compound Identifier 47783. European Medicines Agency schedules Pirquinozol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09941MIG. The term PIRQUINOZOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). PIRQUINOZOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pirquinozol under HS 29335995 and SITC 51576. As of Q4 2014, PIRQUINOZOL remains the US FDA Preferred Term for this commodity. Pirquinozol bears US NLM identifiers UMLS ID C0071153 and NCI Concept Code C90669. SMILES: C1=CC2=C3C=C(NN3C(=O)N=C2C=C1)CO.

